Caesarstone Fixed the Factory. Then the Jury Fixed the Bill.
The turnaround that actually worked
Strip out the courtroom and Caesarstone's third quarter is the best operating print the company has put up in years. Gross margin came in at 25.4% against 17.3% a year ago — an 810 basis point jump, and the fourth consecutive quarter of year-over-year expansion. Adjusted gross margin was 26.9%. Adjusted EBITDA landed at roughly breakeven, a $100,000 loss versus a $7.9 million loss a year ago and a $1.0 million loss in Q2. Revenue of $96.3 million was down 7.2% in constant currency, but that is a demand story, not an execution story.
The execution story is the one management has been telling for two years and it is finally showing up in the P&L. With all Quartz production now in the hands of global production partners, the company has a genuinely lower cost base and a variable cost structure instead of a fixed one. The Bar-Lev closure alone is worth roughly $22 million in annualized cash savings, with more if the noncancelable lease can be sublet, and management now expects total annualized savings to exceed $100 million by 2027 measured against 2023. “The third quarter marked an important milestone in our efforts to restore Caesarstone's profitability.” — Yosef Shiran, Chief Executive Officer · 2026-11-11 That is not spin. It is arithmetic.
The balance sheet is the quiet part of the bull case: $50.7 million of net cash as of September 30 and no debt to financial institutions, down only $1.1 million sequentially despite the loss. For a company with a $44 million market cap, that cash pile is most of the equity story.
Then the jury spoke
On October 26, a California jury returned a verdict in one silica exposure case, apportioning 69% of fault to Caesarstone — approximately $46.8 million if assessed without modification. Note the scale: a single case, one of roughly 176 outstanding U.S. claims, is nominally larger than the entire market capitalization. Operating expenses exploded to $81.4 million, or 84.6% of revenue, against $33.7 million and 33% a year ago, driven by legal settlements and loss contingencies. Net loss attributable to controlling interest was $56.1 million, or $1.62 per share, versus $18.1 million and $0.52.
The verdict has created significant uncertainty regarding the company's financial condition.
That sentence, from a CFO, is the whole dossier. Caesarstone is no longer a margin-recovery story with a litigation overhang; it is a solvency question with a margin-recovery consolation prize. The language is new in kind — available post trial remedies did not exist as a company theme until this quarter, nor did the California jury or the verdict itself, which spiked into the top of the company's momentum movers this period. “We strongly disagree with the recent jury verdict in California and will consider our available post trial remedies as we evaluate its impact on our business.” — Yosef Shiran, Chief Executive Officer · 2026-11-11
The contrast with the company's own prior framing is stark. In May 2025 the CFO walked an analyst through the reserve with a reassuring bottom line: “the net exposure is only $19 million on the book.” — Nahum Trost, Chief Financial Officer · 2025-05-10 Six quarters later, a single adverse verdict is two and a half times that number before any appeal, and the reserve language has hardened from "probable and estimable" to "significant uncertainty."
Equally telling is what vanished. Through 2025, crystalline silica was a durable top-30 keyword — crystalline silica dust, crystalline silica collection, government silica bans, zero-silica collections. This quarter it is absent from the top of the list entirely. The silica conversation has migrated out of the product lab and into the courtroom, and the company no longer talks about chemistry as a liability mitigant. It talks about post-trial remedies.
And then there is the silence. After the CFO's prepared remarks, the operator's next words were: “The conference has now concluded.” — Operator · 2026-11-11 No Q&A. On a day when the company disclosed a verdict it says casts doubt on its financial condition, there was no analyst allowed to ask how an appeal bond gets funded against $50.7 million of net cash and a $44 million market cap. That is the loudest thing in the transcript.
The second invoice: tariffs
Buried beneath the litigation is a slower, better-understood leak. Essentially all U.S.-bound product remains subject to broad based import tariffs at an average tariff rate near 15%, and the U.S. is roughly 40% of revenue. On August 15 a quartz-specific four-year tariff rate quota took effect: a first-year industry quota of about 13 million square meters assessed quarterly, with imports inside the quota paying an additional 25% and above-quota imports paying 50%, rates that step down as the quota steps up. “We estimate the annualized impact of these additional tariffs which apply on top of existing tariffs, at between $10 million and $15 million.” — Nahum Trost, Chief Financial Officer · 2026-11-11 September price increases and a sourcing review are the response.
This is where Caesarstone stops being idiosyncratic. Net tariff refund benefit was among the market's strongest 30-day price movers, and tariff refund language recurred across this week's reporters — ALH, CNH, ONON, GROV and others all booked refunds or quantified tariff drag. Caesarstone's own Q3 gross margin leaned on roughly $900,000 of refunds on previously paid U.S. EPA tariffs. The company is riding an industry-wide tariff wave, not creating one — and unlike the litigation, that wave is legible and priced by peers. Recall how much easier this sounded in May 2025: “We believe that this 10%, we can mitigate the negative effect by working closely with our business partners on the prices.” — Yos Shiran, Chief Executive Officer · 2025-05-10 Ten percent has become fifteen plus a quota surcharge, and the mitigation has become $10-15 million of annualized cost.
What is actually left
The operating geography is genuinely bifurcated. Australia grew 12.2% in constant currency — its fifth consecutive quarter of growth — as the zero-silica ICON collection regains its leading position in a market that banned engineered stone. Canada was flat, EMEA up 0.8%, Israel down 24.9% on soft demand and holiday timing. The U.S. fell 16.9% to $38.8 million on lower quartz volumes in commercial projects, partially offset by big-box growth led by IKEA.
There is a cruel irony here: the zero-silica product built to make the liability obsolete is working in Australia precisely as the U.S. liability crystallizes. Management spent two years arguing the silica cases were a reserve line, not an existential one. “I don't think it has any impact on demand. We are suffering because of other reasons, but not because of this reason.” — Yosef Shiran, Chief Executive Officer · 2025-08-07 The question now is not demand. It is whether $50.7 million of net cash, roughly $100 million of eventual run-rate savings, and a possible appeal survive one $46.8 million judgment. The factory is fixed. The bill is not.